A Randomized, Double-Blind 4-Week Study to Evaluate the Impact of AXS-05 on Smoking Behavior
Phase of Trial: Phase II
Latest Information Update: 21 Jan 2019
At a glance
- Drugs Bupropion/dextromethorphan (Primary) ; Bupropion
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 11 Jan 2019 Planned End Date changed from 21 Jan 2019 to 31 May 2019.
- 11 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Mar 2019.
- 27 Dec 2018 According to an Axsome Therapeutics media release, top-line results are anticipated in the first quarter of 2019.